New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 11, 2014
10:46 EDTMNKD, QCOR, NQ, WWE, BBBYOptions with decreasing implied volatility: MNKD QCOR NQ WWE BBBY
News For MNKD;QCOR;NQ;WWE;BBBY From The Last 14 Days
Check below for free stories on MNKD;QCOR;NQ;WWE;BBBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 12, 2014
13:27 EDTNQNQ Mobile move positive attributed to iTunes link
Subscribe for More Information
11:15 EDTMNKDOptions with decreasing implied volatility
Subscribe for More Information
10:10 EDTWWEWWE notes OTT international launches of WWE Network
Subscribe for More Information
August 11, 2014
16:31 EDTWWEEminence Capital reports 9.6% passive stake in WWE
Subscribe for More Information
16:00 EDTMNKDOptions Update; August 11, 2014
iPath S&P 500 VIX Short-Term Futures down 1.33 to 31.90. Option volume leaders: AAPL KMI MNKD PBR AMZN SCTY TWTR TSLA according to Track Data.
15:51 EDTMNKDMannKind price target raised to $10 from $6.50 at Piper Jaffray
Subscribe for More Information
11:58 EDTMNKDMannKind rallies after inking licensing agreement with Sanofi
Subscribe for More Information
11:28 EDTMNKDOptions with decreasing implied volatility
Options with decreasing implied volatility: GRPN MNKD UBNT OLED ZU RPTP SALE UNXL FEYE VNDA
10:09 EDTMNKDMannKind rallies after global licensing agreement for Afrezza
Subscribe for More Information
09:36 EDTMNKDActive equity options trading on open
Subscribe for More Information
09:07 EDTMNKDMannKind reports Q2 EPS (19c), consensus (12c)
Subscribe for More Information
09:06 EDTMNKDOn The Fly: Pre-market Movers
HIGHER: PharmAthene (PIP), up 55% after announcing that a Delaware court awarded the company lump sum expectation damages for the value of its lost profits for SIGA Technologies' (SIGA) smallpox antiviral, Tecovirimat... MannKind (MNKD), up 19% after entering exclusive licensing agreement for development and commercialization of Afrezza inhaled insulin with Sanofi (SNY)... Kinder Morgan (KMI), up 19% after announcing it will acquire all of the outstanding equity securities of Kinder Morgan Energy Partners (KMP), Kinder Morgan Management (KMR) and El Paso Pipeline Partners (EPB)... Tesla (TSLA), up 2.7% following upgrade at Deutsche Bank... Achillion (ACHN), up 6% following upgrades at Wells Fargo and at Piper Jaffray... PepsiCo (PEP), up 0.9% following upgrade at UBS. LOWER: Dean Foods (DF), down 8.6% after reporting Q2 losses that were steeper than expected, saying balance of year "appears rocky," which makes it difficult to provide guidance beyond the immediate quarter... Priceline (PCLN), down 0.7% after reporting Q2 revenue that missed expectations, guiding Q3 EPS below consensus... SIGA Technologies, down 31% after ruling in suit with PharmAthene... 2U (TWOU), down 4.3% after downgraded at Goldman.
07:45 EDTMNKDMannKind partnership likely to be viewed favorably, says Piper Jaffray
Subscribe for More Information
07:05 EDTBBBYDeutsche Bank discusses LBO chatter in Retail space
Subscribe for More Information
06:31 EDTMNKDMannKind to host conference call
Conference call to discuss the collaboration with Sanofi about global licensing agreement for development and commercialization of Afrezza will be held on August 11 at 8:30 am. Webcast Link
05:13 EDTMNKDSanofi, MannKind announce global licensing agreement for Afrezza
Subscribe for More Information
August 8, 2014
13:35 EDTMNKDMannKind August volatility elevated into Q2 and outlook
Subscribe for More Information
07:45 EDTQCORMallinckrodt price target lowered to $77 from $90 at Leerink
Leerink lowered its price target for Mallinckrodt (MNK) shares to $77 citing a heightened risk profile from the Questcor (QCOR) acquisition and significant earnings concentration in Acthar. The firm says it remains on the sidelines with a Market Perform rating on Mallinckrodt.
07:44 EDTQCORMallinckrodt remains favorite specialty pharmaceutical name, says UBS
UBS said Mallinckrodt (MNK) remains its favorite specialty pharmaceutical name following the company's update on its merger with Questcor (QCOR). The firm sees estimates increasing following the close of the transaction, the divestiture of the Medical Imaging division, and the reinvestment in higher margin assets. UBS has a Buy rating with a $94 price target on Mallinckrodt.
05:59 EDTMNKDStocks with implied volatility movement; MNKD LULU
Stocks with implied volatility movement; MannKind (MNKD) 116, lululemon (LULU) 39 according to iVolatility.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use